SCHEMBL23130166

SCHEMBL23130166

CCOC(=O)c1c(Cl)ccc2c1OB(O)C(NC(=O)CC)C2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 4/20 0.36
▸ GRM6 O15303 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ RAB9A P51151 3/20 0.33
▸ ADORA2B P29275 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ PRKCZ Q05513 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ MAPT P10636 2/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ CA12 O43570 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CA7 P43166 1/20 0.32
▸ CA9 Q16790 1/20 0.32
▸ CA14 Q9ULX7 1/20 0.32
▸ NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17347832 1.00 ALOX5 (0.36) ALOX5GRM6POLBRAB9AADORA2B
SCHEMBL17347806 0.92 ALOX5 (0.37) ALOX5POLBRAB9AADORA2BMEN1
SCHEMBL23130177 0.92 ALOX5 (0.37) ALOX5POLBRAB9AADORA2BMEN1
SCHEMBL17347744 0.90 ALOX5 (0.36) ALOX5GRM6POLBRAB9AADORA2B
SCHEMBL23129690 0.90 ALOX5 (0.36) ALOX5GRM6POLBRAB9AADORA2B
SCHEMBL19663664 0.89 ALDH1A1 (0.34) RAB9AADORA2BMEN1KMT2AALDH1A1
SCHEMBL23129709 0.88 CA12 (0.41) RAB9AMEN1KMT2AALDH1A1HPGD
SCHEMBL17347783 0.88 CA12 (0.41) RAB9AMEN1KMT2AALDH1A1HPGD
SCHEMBL17347789 0.88 MTNR1A (0.33) MEN1KMT2AALDH1A1MAPK1CA12
SCHEMBL23130023 0.88 MTNR1A (0.33) MEN1KMT2AALDH1A1MAPK1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3154989-B1 BETA-LACTAMASE INHIBITORS VENATORX PHARMACEUTICALS INC (US) 2021-03-24 — — EP disclosed
Send feedback